United Kingdom

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

23 Mar 2018
Change (% chg)

$-0.29 (-6.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Cerecor announces leadership changes
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cerecor Inc :Cerecor announces leadership changes.Cerecor Inc - ‍Interim Chief Executive Officer John Kaiser and Chief Medical Officer Dr. Ronald Marcus stepping down​.Cerecor Inc - ‍Appoints Randal O. Jones and Robert C. Moscato, Jr. to board of directors​.Cerecor Inc - ‍ Names Robert Moscato as president and Chief Operating Officer​.Cerecor Inc - ‍Mariam Morris will continue as Cerecor's chief financial officer​.  Full Article

Cerecor reports Q3 earnings per share of $0.52
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cerecor Inc ::Cerecor Inc reports third quarter 2017 financial results.Q3 earnings per share $0.52.As of Sept 30, cash and cash equivalents were $24.0 million, escrowed cash receivable was $3.75 million and current liabilities were $4.8 million​.Expect existing cash and cash equivalents, initial proceeds from Janssen sale will fund operating expenditures through at least 2018​.  Full Article

Cerecor announces last patient enrolled in phase 2 clinical trial with CERC-501 for smoking cessation
Tuesday, 6 Sep 2016 

Cerecor Inc : Cerecor Announces Last Patient Enrolled In Phase 2 Clinical Trial With CERC-501 for smoking cessation . Top-Line phase 2 data expected in December 2016 .Planning to initiate a phase 2 study with CERC-501 as an adjunctive treatment of MDD in 2017.  Full Article

Cerecor Inc Q2 loss per share $0.41
Monday, 15 Aug 2016 

Cerecor Inc : Cerecor Inc reports second quarter 2016 financial results .Q2 loss per share $0.41.  Full Article

Cerecor Inc Q1 loss per share $0.59
Monday, 16 May 2016 

Cerecor Inc : Cerecor Inc. Reports first quarter 2016 financial results .Q1 loss per share $0.59.  Full Article